Rowena C. Punzalan

737 total citations
23 papers, 480 citations indexed

About

Rowena C. Punzalan is a scholar working on Hematology, Internal Medicine and Genetics. According to data from OpenAlex, Rowena C. Punzalan has authored 23 papers receiving a total of 480 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Hematology, 10 papers in Internal Medicine and 5 papers in Genetics. Recurrent topics in Rowena C. Punzalan's work include Venous Thromboembolism Diagnosis and Management (10 papers), Blood Coagulation and Thrombosis Mechanisms (8 papers) and Platelet Disorders and Treatments (5 papers). Rowena C. Punzalan is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (10 papers), Blood Coagulation and Thrombosis Mechanisms (8 papers) and Platelet Disorders and Treatments (5 papers). Rowena C. Punzalan collaborates with scholars based in United States, Netherlands and Norway. Rowena C. Punzalan's co-authors include Sheila J. Hanson, Peter L. Havens, John P. Scott, Cheryl A. Hillery, Rachel A. Greenup, Melissa Christensen, Thomas T. Sato, Hua Liu, Pippa Simpson and Ke Yan and has published in prestigious journals such as Journal of Biological Chemistry, Blood and British Journal of Haematology.

In The Last Decade

Rowena C. Punzalan

23 papers receiving 469 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rowena C. Punzalan United States 12 250 223 126 109 95 23 480
L. Brooker Canada 10 293 1.2× 545 2.4× 162 1.3× 114 1.0× 75 0.8× 10 673
Alain Vuillemenot France 11 297 1.2× 78 0.3× 409 3.2× 362 3.3× 17 0.2× 22 651
Anasua Chakraborty United States 6 537 2.1× 25 0.1× 358 2.8× 101 0.9× 127 1.3× 9 634
U. Nowak-Göttl Germany 10 170 0.7× 319 1.4× 92 0.7× 93 0.9× 31 0.3× 20 432
P Powers Canada 6 465 1.9× 75 0.3× 285 2.3× 212 1.9× 92 1.0× 8 543
J. Fernández Llamazares Spain 7 225 0.9× 29 0.1× 97 0.8× 205 1.9× 144 1.5× 17 372
Elizabeth Ling Canada 11 44 0.2× 22 0.1× 54 0.4× 233 2.1× 23 0.2× 16 507
Jean Leroy France 8 88 0.4× 200 0.9× 135 1.1× 108 1.0× 7 0.1× 9 361
W. Habscheid Germany 9 190 0.8× 14 0.1× 68 0.5× 164 1.5× 43 0.5× 35 317
J McLACHLIN Canada 7 339 1.4× 79 0.4× 138 1.1× 165 1.5× 76 0.8× 10 425

Countries citing papers authored by Rowena C. Punzalan

Since Specialization
Citations

This map shows the geographic impact of Rowena C. Punzalan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rowena C. Punzalan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rowena C. Punzalan more than expected).

Fields of papers citing papers by Rowena C. Punzalan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rowena C. Punzalan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rowena C. Punzalan. The network helps show where Rowena C. Punzalan may publish in the future.

Co-authorship network of co-authors of Rowena C. Punzalan

This figure shows the co-authorship network connecting the top 25 collaborators of Rowena C. Punzalan. A scholar is included among the top collaborators of Rowena C. Punzalan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rowena C. Punzalan. Rowena C. Punzalan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chonat, Satheesh, Alexander Kulagin, Alexey Maschan, et al.. (2024). Pharmacokinetics, pharmacodynamics, efficacy, and safety of ravulizumab in pediatric paroxysmal nocturnal hemoglobinuria. Blood Advances. 8(11). 2813–2824. 5 indexed citations
2.
Landisch, Rachel M., et al.. (2018). Efficacy of surveillance ultrasound for venous thromboembolism diagnosis in critically ill children after trauma. Journal of Pediatric Surgery. 53(11). 2195–2201. 7 indexed citations
3.
Hanson, Sheila J., et al.. (2018). Central Venous Catheter–associated Venous Thromboembolism in Children With Hematologic Malignancy. Journal of Pediatric Hematology/Oncology. 40(8). e519–e524. 13 indexed citations
4.
Landisch, Rachel M., et al.. (2017). Evaluation of guidelines for injured children at high risk for venous thromboembolism. The Journal of Trauma: Injury, Infection, and Critical Care. 82(5). 836–844. 19 indexed citations
5.
Punzalan, Rowena C. & Jerome L. Gottschall. (2016). Use and Future Investigations of Recombinant and Plasma-Derived Coagulation and Anticoagulant Products in the Neonate. Transfusion Medicine Reviews. 30(4). 189–196. 7 indexed citations
6.
Niebler, Robert A., Katherine Woods, Kathleen Murkowski, et al.. (2015). A Pilot Study of Antithrombin Replacement Prior to Cardiopulmonary Bypass in Neonates. Artificial Organs. 40(1). 80–85. 7 indexed citations
7.
Scott, John P., George M. Hoffman, Pippa Simpson, et al.. (2014). Increased recombinant activated factor VII use and need for surgical reexploration following a switch from aprotinin to epsilon-aminocaproic acid in infant cardiac surgery. Journal of Clinical Anesthesia. 26(3). 204–211. 10 indexed citations
8.
Abu‐Sultaneh, Samer, Sheila J. Hanson, Ke Yan, et al.. (2014). Higher Doses of Low-Molecular-Weight Heparin (Enoxaparin) Are Needed to Achieve Target Anti-Xa Concentrations in Critically Ill Children*. Pediatric Critical Care Medicine. 15(7). e294–e299. 17 indexed citations
9.
Scott, James G., et al.. (2013). Severe Thrombocytopenia in a Child Secondary to Passive Platelet Antibody Transfer from a Plasma Transfusion. Journal of Pediatric Hematology/Oncology. 35(5). e226–e228. 2 indexed citations
10.
Rangarajan, Hemalatha G., Rowena C. Punzalan, Bruce M. Camitta, & Julie‐An Talano. (2013). The use of novel Therakos™ Cellex® for extracorporeal photopheresis in treatment of graft‐versus‐host disease in paediatric patients. British Journal of Haematology. 163(3). 357–364. 17 indexed citations
11.
Punzalan, Rowena C., et al.. (2012). Use of purified fibrinogen concentrate for dysfibrinogenemia and importance of laboratory fibrinogen activity measurement. Pediatric Blood & Cancer. 60(3). 500–502. 7 indexed citations
12.
Hanson, Sheila J., Rowena C. Punzalan, Marjorie J. Arca, et al.. (2012). Effectiveness of clinical guidelines for deep vein thrombosis prophylaxis in reducing the incidence of venous thromboembolism in critically ill children after trauma. The Journal of Trauma: Injury, Infection, and Critical Care. 72(5). 1292–1297. 68 indexed citations
13.
Hanson, Sheila J., Rowena C. Punzalan, Melissa Christensen, et al.. (2011). Incidence and Risk Factors for Venous Thromboembolism in Critically Ill Children With Cardiac Disease. Pediatric Cardiology. 33(1). 103–108. 37 indexed citations
14.
Hanson, Sheila J., Rowena C. Punzalan, Rachel A. Greenup, et al.. (2010). Incidence and Risk Factors for Venous Thromboembolism in Critically Ill Children After Trauma. The Journal of Trauma: Injury, Infection, and Critical Care. 68(1). 52–56. 83 indexed citations
15.
Gupta, Sweta, et al.. (2010). Trimethoprim-induced immune hemolytic anemia in a pediatric oncology patient presenting as an acute hemolytic transfusion reaction. Pediatric Blood & Cancer. 55(6). 1201–1203. 7 indexed citations
16.
Niebler, Robert A., et al.. (2009). Activated recombinant factor VII for refractory bleeding during extracorporeal membrane oxygenation*. Pediatric Critical Care Medicine. 11(1). 98–102. 29 indexed citations
17.
Hanson, Sheila J., Rowena C. Punzalan, Nancy S. Ghanayem, & Peter L. Havens. (2007). Prevalence of heparin-dependent platelet antibodies in children after cardiopulmonary bypass*. Pediatric Critical Care Medicine. PAP(4). 358–61. 8 indexed citations
18.
Wandersee, Nancy J., Rowena C. Punzalan, Michael P. Rettig, et al.. (2005). Erythrocyte adhesion is modified by alterations in cellular tonicity and volume. British Journal of Haematology. 131(3). 366–377. 29 indexed citations
19.
Greenbaum, Larry A., Bryce A. Kerlin, Scott Van Why, et al.. (2003). Concurrent poststreptococcal glomerulonephritis and autoimmune hemolytic anemia. Pediatric Nephrology. 18(12). 1301–1303. 11 indexed citations
20.
Punzalan, Rowena C., et al.. (2000). Low-Molecular-Weight Heparin in Thrombotic Disease in Children and Adolescents. ˜The œAmerican journal of pediatric hematology/oncology. 22(2). 137–142. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by L. Brooker Breakdown of academic impact, for papers by Alain Vuillemenot Breakdown of academic impact, for papers by Anasua Chakraborty Breakdown of academic impact, for papers by U. Nowak-Göttl Breakdown of academic impact, for papers by P Powers Breakdown of academic impact, for papers by J. Fernández Llamazares Breakdown of academic impact, for papers by Elizabeth Ling Breakdown of academic impact, for papers by Jean Leroy Breakdown of academic impact, for papers by W. Habscheid Breakdown of academic impact, for papers by J McLACHLIN
Rankless by CCL
2026